Full text
PDF![596](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/376a/1648589/20d3c271939a/archdisch00862-0030.png)
![597](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/376a/1648589/b44e83014715/archdisch00862-0031.png)
![598](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/376a/1648589/f5c6493ca5b9/archdisch00862-0032.png)
![599](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/376a/1648589/07e81024f13b/archdisch00862-0033.png)
![600](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/376a/1648589/b828e8a22a94/archdisch00862-0034.png)
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- ALMQVIST S., RUNE I. Studies on sulfation factor (SF) activity of human serum. The variation of serum SF with age. Acta Endocrinol (Copenh) 1961 Apr;36:566–576. doi: 10.1530/acta.0.0360566. [DOI] [PubMed] [Google Scholar]
- ALMQVIST S. Studies on sulfation factor (SF) activity of human serum. Effect of human growth hormone on SF levels in pituitary dwarfism. Acta Endocrinol (Copenh) 1960 Nov;35:381–396. doi: 10.1530/acta.0.xxxv0381. [DOI] [PubMed] [Google Scholar]
- DAUGHADAY W. H., SALMON W. D., Jr, ALEXANDER F. Sulfation factor activity of sera from patients with pituitary disorders. J Clin Endocrinol Metab. 1959 Jul;19(7):743–758. doi: 10.1210/jcem-19-7-743. [DOI] [PubMed] [Google Scholar]
- Daughaday W. H., Kipnis D. M. The growth-promoting and anti-insulin actions of somatotropin. Recent Prog Horm Res. 1966;22:49–99. doi: 10.1016/b978-1-4831-9825-5.50005-1. [DOI] [PubMed] [Google Scholar]
- Daughaday W. H. Sulfation factor regulation of skeletal growth. A stable mechanism dependent on intermittent growth hormone secretion. Am J Med. 1971 Mar;50(3):277–280. doi: 10.1016/0002-9343(71)90214-2. [DOI] [PubMed] [Google Scholar]
- Hall K., Olin P. Sulphation factor activity and growth rate during long-term treatment of patients with pituitary dwarfism with human growth hormone. Acta Endocrinol (Copenh) 1972 Mar;69(3):417–433. doi: 10.1530/acta.0.0690417. [DOI] [PubMed] [Google Scholar]
- Hall K. Quantative determination of the sulphation factor activity in human serum. Acta Endocrinol (Copenh) 1970 Feb;63(2):338–350. doi: 10.1530/acta.0.0630338. [DOI] [PubMed] [Google Scholar]
- KOGUT M. D., KAPLAN S. A., SHIMIZU C. S. Growth retardation: use of sulfation factor as a bioassay for growth hormone. Pediatrics. 1963 Apr;31:538–551. [PubMed] [Google Scholar]
- Laron Z., Pertzelan A., Karp M., Kowadlo-Silbergeld A., Daughaday W. H. Administration of growth hormone to patients with familial dwarfism with high plasma immunoreactive growth hormone: measurement of sulfation factor, metabolic and linear growth responses. J Clin Endocrinol Metab. 1971 Aug;33(2):332–342. doi: 10.1210/jcem-33-2-332. [DOI] [PubMed] [Google Scholar]
- Mancini G., Carbonara A. O., Heremans J. F. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry. 1965 Sep;2(3):235–254. doi: 10.1016/0019-2791(65)90004-2. [DOI] [PubMed] [Google Scholar]
- McConaghey P., Sledge C. B. Production of "sulphation factor" by the perfused liver. Nature. 1970 Mar 28;225(5239):1249–1250. doi: 10.1038/2251249b0. [DOI] [PubMed] [Google Scholar]
- SALMON W. D., Jr, DAUGHADAY W. H. A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro. J Lab Clin Med. 1957 Jun;49(6):825–836. [PubMed] [Google Scholar]
- Tanner J. M. Human growth hormone. Nature. 1972 Jun 23;237(5356):433–439. doi: 10.1038/237433a0. [DOI] [PubMed] [Google Scholar]
- Van den Brande J. L., Van Wyk J. J., Weaver R. P., Mayberry H. E. Partial characterization of sulphation and thymidine factors in acromegalic plasma. Acta Endocrinol (Copenh) 1971 Jan;66(1):65–81. doi: 10.1530/acta.0.0660065. [DOI] [PubMed] [Google Scholar]
- Whitehead R. G., Alleyne G. A. Pathophysiological factors of importance in protein-calorie malnutrition. Br Med Bull. 1972 Jan;28(1):72–79. doi: 10.1093/oxfordjournals.bmb.a070897. [DOI] [PubMed] [Google Scholar]